Skip to content

Cohort study of Chinese medicine Weichangan for strengthening the spleen and gene characteristics analysis on advanced colorectal cancer

Cohort study of Chinese medicine Weichangan for strengthening the spleen and gene characteristics analysis on advanced colorectal cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003857
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Sponsors

Longhua Hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) A clear pathological diagnosis is a patient with colorectal cancer; (2) Have complete TNM staging information; (3) There is a clear diagnosis of the location and time of metastasis; (4) Aged >= 18 years and <= 80 years, male or female; (5) There is a clear time for the first treatment with Chinese medicine; (6) Patients who can receive long-term follow-up.

Exclusion criteria

Exclusion criteria: (1) Patients with colorectal cancer diagnosed pathologically as adenosquamous carcinoma, squamous cell carcinoma, carcinoid, small cell carcinoma, malignant lymphoma, etc.; (2) Patients with double cancer, multiple or metastatic colorectal cancer; (3) Combined with severe acute and chronic diseases that may affect treatment and prognosis, such as myocardial infarction, stroke, severe renal insufficiency and mental illness.

Design outcomes

Primary

MeasureTime frame
Progression Free Survival;

Secondary

MeasureTime frame
Overall Survival;

Countries

China

Contacts

Public ContactMeng Dan

Longhua Hospital Shanghai University of Traditional Chinese Medicine

mengdan703@163.com+86 15821161395

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026